FBLG FibroBiologics, Inc.
$1.61▼ -6.94%
Healthcare
Other
After hours
$1.64▲ +1.86%
Sep 11, 7:30 PM ET
Volume 107.3K
Avg Volume (10D) 400.2K
Key Metrics & Fundamentals
Market Cap
$10.72M
P/E Ratio
–
Div Yield
–%
52W Range
0.62 - 12.40
% vs 50 MA
44.68%
% vs 200 MA
-49.05%
RSI-14
56.4
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.26
Free Cash Flow
-$3.29M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.95M
COGS
–
Operating Exp
$4.03M
Operating Income
-$4.03M
EBIT
-$4.03M
Pretax Income
-$4.12M
Net Income
-$4.12M
EPS (Diluted)
-0.66
Price & Volume History
Loading chart…
Recent News
Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based Cell Therapy Platform Across Multiple High-Value Indications
ACCESS Newswire · Sep 8, 2026 1:00 PM
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
PR Newswire · Sep 3, 2026 12:30 PM
FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media
PR Newswire · Sep 1, 2026 12:30 PM
FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
PR Newswire · Aug 27, 2026 12:30 PM
FibroBiologics advances diabetic ulcer trial with new drug shipment to Australia
Proactive · Aug 27, 2026 8:25 AM
FibroBiologics Regains Compliance with Nasdaq Trading Rules
PR Newswire · Aug 26, 2026 12:30 PM
FibroBiologics Appoints Leigh Steinberg to Board of Directors
PR Newswire · Aug 24, 2026 12:30 PM
FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease
PR Newswire · Aug 20, 2026 12:30 PM
FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints
PR Newswire · Aug 18, 2026 12:30 PM
FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets
PR Newswire · Aug 11, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See FBLG's money flow as a full page
Social Sentiment
Avg +0.90 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.